Notes / Company

Morepen Laboratories Ltd.

MOREPENLAB BSE 500288 ISIN INE083A01026 Pharmaceuticals

Fundamentals

Market cap: ₹2,351 cr
P/E: 23.64×
ROE: 10.21%
Debt / equity: 0.07
Div yield: 0.47%
52-week range: 33.05 — 70.50

Research on Tijori Finance

The timeline — 1 note on Morepen Laboratories Ltd.

May 2026

20 May 26 · 19:11 IST Brief

Brief

Morepen locks in medical devices chief with subsidiary shares

The company transferred 1,62,000 shares of Morepen Medipath to Anubhav Suri, reducing its stake from 60% to 51% while retaining control. No price was disclosed.

Verify on exchange BSE filings for MOREPENLAB NSE filings for MOREPENLAB Tijori Finance company page